These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23509688)

  • 1. Downregulation of DLC-1 gene by promoter methylation during primary colorectal cancer progression.
    Peng H; Long F; Wu Z; Chu Y; Li J; Kuai R; Zhang J; Kang Z; Zhang X; Guan M
    Biomed Res Int; 2013; 2013():181384. PubMed ID: 23509688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter hypermethylation along with LOH, but not mutation, contributes to inactivation of DLC-1 in nasopharyngeal carcinoma.
    Feng X; Ren C; Zhou W; Liu W; Zeng L; Li G; Wang L; Li M; Zhu B; Yao K; Jiang X
    Mol Carcinog; 2014 Nov; 53(11):858-70. PubMed ID: 23908159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic silencing of HOPX promotes cancer progression in colorectal cancer.
    Katoh H; Yamashita K; Waraya M; Margalit O; Ooki A; Tamaki H; Sakagami H; Kokubo K; Sidransky D; Watanabe M
    Neoplasia; 2012 Jul; 14(7):559-71. PubMed ID: 22904674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer.
    Luo Y; Wong CJ; Kaz AM; Dzieciatkowski S; Carter KT; Morris SM; Wang J; Willis JE; Makar KW; Ulrich CM; Lutterbaugh JD; Shrubsole MJ; Zheng W; Markowitz SD; Grady WM
    Gastroenterology; 2014 Aug; 147(2):418-29.e8. PubMed ID: 24793120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation pattern of the O6-methylguanine-DNA methyltransferase gene in colon during progressive colorectal tumorigenesis.
    Nagasaka T; Goel A; Notohara K; Takahata T; Sasamoto H; Uchida T; Nishida N; Tanaka N; Boland CR; Matsubara N
    Int J Cancer; 2008 Jun; 122(11):2429-36. PubMed ID: 18240147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic inactivation of DLC-1 in supratentorial primitive neuroectodermal tumor.
    Pang JC; Chang Q; Chung YF; Teo JG; Poon WS; Zhou LF; Kong X; Ng HK
    Hum Pathol; 2005 Jan; 36(1):36-43. PubMed ID: 15712180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer.
    Liu M; Peng Y; Wang X; Guo Q; Shen S; Li G
    BMC Cancer; 2010 Apr; 10():160. PubMed ID: 20423473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells.
    Kim TY; Jong HS; Song SH; Dimtchev A; Jeong SJ; Lee JW; Kim TY; Kim NK; Jung M; Bang YJ
    Oncogene; 2003 Jun; 22(25):3943-51. PubMed ID: 12813468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
    Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
    Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma.
    Wong CM; Lee JM; Ching YP; Jin DY; Ng IO
    Cancer Res; 2003 Nov; 63(22):7646-51. PubMed ID: 14633684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.
    Xu XL; Yu J; Zhang HY; Sun MH; Gu J; Du X; Shi DR; Wang P; Yang ZH; Zhu JD
    World J Gastroenterol; 2004 Dec; 10(23):3441-54. PubMed ID: 15526363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter hypermethylation of DLC-1, a candidate tumor suppressor gene, in several common human cancers.
    Yuan BZ; Durkin ME; Popescu NC
    Cancer Genet Cytogenet; 2003 Jan; 140(2):113-7. PubMed ID: 12645648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DLC-1 is a candidate biomarker methylated and down-regulated in pancreatic ductal adenocarcinoma.
    Xue YZ; Wu TL; Wu YM; Sheng YY; Wei ZQ; Lu YF; Yu LH; Li JP; Li ZS
    Tumour Biol; 2013 Oct; 34(5):2857-61. PubMed ID: 23681804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene promoter and exon DNA methylation changes in colon cancer development - mRNA expression and tumor mutation alterations.
    Molnár B; Galamb O; Péterfia B; Wichmann B; Csabai I; Bodor A; Kalmár A; Szigeti KA; Barták BK; Nagy ZB; Valcz G; Patai ÁV; Igaz P; Tulassay Z
    BMC Cancer; 2018 Jun; 18(1):695. PubMed ID: 29945573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative assessment of AKAP12 promoter methylation in colorectal cancer using methylation-sensitive high resolution melting: Correlation with Duke's stage.
    Liu W; Guan M; Su B; Ye C; Li J; Zhang X; Liu C; Li M; Lin Y; Lu Y
    Cancer Biol Ther; 2010 Jun; 9(11):862-71. PubMed ID: 20364105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence.
    Lee KH; Lee JS; Nam JH; Choi C; Lee MC; Park CS; Juhng SW; Lee JH
    Langenbecks Arch Surg; 2011 Oct; 396(7):1017-26. PubMed ID: 21706233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: potential clinical applications.
    Guan M; Zhou X; Soulitzis N; Spandidos DA; Popescu NC
    Clin Cancer Res; 2006 Mar; 12(5):1412-9. PubMed ID: 16533763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High frequency of genes' promoter methylation, but lack of BRAF V600E mutation among Iranian colorectal cancer patients.
    Naghibalhossaini F; Hosseini HM; Mokarram P; Zamani M
    Pathol Oncol Res; 2011 Dec; 17(4):819-25. PubMed ID: 21455633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration.
    Ma SS; Srivastava S; Llamosas E; Hawkins NJ; Hesson LB; Ward RL; Ford CE
    BMC Cancer; 2016 Jul; 16():508. PubMed ID: 27440078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.